Table 2. Tumour responses after eight cycles of chemotherapy (by treatment arm).
|
Carboplatin followed by docetaxel alone (arm A) (n=25)
|
Carboplatin followed by docetaxel–gemcitabine (3-weekly) (arm B) (n=22)
|
Carboplatin followed by docetaxel–gemcitabine (weekly) (arm C) (n=23)
|
||||
|---|---|---|---|---|---|---|
| Response | % | Count | % | Count | % | Count |
| CR | 40.0 | 10 | 45.5 | 10 | 30.4 | 7 |
| PR | 44.0 | 11 | 31.8 | 7 | 39.1 | 9 |
| Stable | 8.0 | 2 | 9.1 | 2 | 8.7 | 2 |
| Progression | 8.0 | 2 | 4.5 | 1 | 13.0 | 3 |
| Unevaluable | 0.0 | 0 | 9.1 | 2 | 8.7 | 2 |
CR=complete response; PR=partial response.